Get In Touch

The STIMEL-03 holds FDA 510(k) clearance, CE Mark (EU MDR), TGA approval (Australia), and Health Canada approval. The Spatial StimelMD has received FDA Breakthrough Device Designation.

We offer comprehensive training programs for healthcare providers. Contact our clinical education team to schedule a training session at your facility or attend one of our regional workshops.

Our devices address spinal cord injury, stroke rehabilitation, ALS, multiple sclerosis, and other conditions involving motor neuron dysfunction. Contact our clinical team for condition-specific protocols.

Yes. We offer 30-day clinical evaluation units for qualified healthcare institutions. Contact our sales team to arrange a demonstration and evaluation program.